Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
26.7%
% of XLV's 60 holdings also in AGNG
19.5%
% of AGNG's 82 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus AGNG)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in AGNG |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.4% | 3.3% | 3.3% |
|
JOHNSON & JOHNSON | 7.7% | 3.0% | 3.0% |
|
AMGEN INC | 3.0% | 2.9% | 2.9% |
|
MERCK & CO. INC. | 4.0% | 2.9% | 2.9% |
|
BOSTON SCIENTIFIC CORP | 2.8% | 3.0% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to AGNG
|
ELI LILLY & CO | 10.1% |
|
UNITEDHEALTH GROUP INC | 8.5% |
|
JOHNSON & JOHNSON | 4.7% |
|
ABBOTT LABORATORIES | 4.6% |
|
INTUITIVE SURGICAL INC | 3.5% |
|
ABBVIE INC | 3.3% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
GILEAD SCIENCES INC | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.5% |
|
PFIZER INC | 2.5% |
XLV Underweight Relative to AGNG
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.2% |
 |
ALCON, INC. | -3.1% |
|
WELLTOWER, INC. | -3.1% |
|
ROCHE HOLDING AG-BR | -3.1% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.0% |
 |
NOVO NORDISK A/S-B | -2.9% |
 |
UCB SA | -2.8% |
|
VENTAS INC | -2.5% |
|
TERUMO CORP | -2.4% |
|
EDWARDS LIFESCIENCES CORP | -2.2% |